Page last updated: 2024-10-31

mitoxantrone and Leukemia, Prolymphocytic

mitoxantrone has been researched along with Leukemia, Prolymphocytic in 2 studies

Mitoxantrone: An anthracenedione-derived antineoplastic agent.
mitoxantrone : A dihydroxyanthraquinone that is 1,4-dihydroxy-9,10-anthraquinone which is substituted by 6-hydroxy-1,4-diazahexyl groups at positions 5 and 8.

Leukemia, Prolymphocytic: A chronic leukemia characterized by a large number of circulating prolymphocytes. It can arise spontaneously or as a consequence of transformation of CHRONIC LYMPHOCYTIC LEUKEMIA.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Valiev, TT1
Vinogradova, IuE1
Chernova, NG1
Mar'in, DS1
Volkova, IaK1
Petrova, VI1
Bulanov, AIu1
Kalinin, NN1
Semenova, EA1
Gretsov, EM1
Kravchenko, SK1
Kremenetskaia, AM1
Vorob'ev, AI1
Styczynski, J1
Pieters, R1
Huismans, DR1
Schuurhuis, GJ1
Wysocki, M1
Veerman, AJ1

Other Studies

2 other studies available for mitoxantrone and Leukemia, Prolymphocytic

ArticleYear
[Remission in T-cell prolymphocytic leukemia during the FMC treatment course].
    Terapevticheskii arkhiv, 2006, Volume: 78, Issue:7

    Topics: Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Humans; Leukemia, Prolymphocytic;

2006
In vitro drug resistance profiles of adult versus childhood acute lymphoblastic leukaemia.
    British journal of haematology, 2000, Volume: 110, Issue:4

    Topics: Adolescent; Adult; Age Factors; Antineoplastic Agents; Asparaginase; Bone Marrow Cells; Child; Child

2000